Pure Red-Cell Aplasia Associated with Clonal Expansion of Granular Lymphocytes Expressing Killer-Cell Inhibitory Receptors
about
CD4+,CD28- T cells in rheumatoid arthritis patients combine features of the innate and adaptive immune systems.TCRgammadelta+ large granular lymphocyte leukemias reflect the spectrum of normal antigen-selected TCRgammadelta+ T-cells.Autoimmune cytopenias in chronic lymphocytic leukemia.Pure red cell aplasia.Fibrosis and subsequent cytopenias are associated with basic fibroblast growth factor-deficient pluripotent mesenchymal stromal cells in large granular lymphocyte leukemia.Pure red cell aplasia associated with type I autoimmune polyglandular syndrome-successful response to treatment with mycophenolate mofetil: case report and review of literature.Gamma/delta T-cell receptor type granular lymphocyte proliferative disorder associated with rheumatoid arthritis.T-large granular lymphocyte leukemia: current molecular concepts.Phenotypic differences between healthy effector CTL and leukemic LGL cells support the notion of antigen-triggered clonal transformation in T-LGL leukemia.Clonal predominance of CD8(+) T cells in patients with unexplained neutropeniaThe root of many evils: indolent large granular lymphocyte leukaemia and associated disorders.Use of NK cell activity in cure by transplant.Anemia in malignancies: pathogenetic and diagnostic considerations.Oral cyclophosphamide was effective for Coombs-negative autoimmune hemolytic anemia in CD16+CD56- chronic lymphoproliferative disorder of NK-cells.Long-term outcome of patients with acquired chronic pure red cell aplasia (PRCA) following immunosuppressive therapy: a final report of the nationwide cohort study in 2004/2006 by the Japan PRCA collaborative study group.Clinical Features, Pathogenesis, and Treatment of Large Granular Lymphocyte Leukemias.Celiac disease with pure red cell aplasia: an unusual hematologic association in pediatric age groupLarge granular lymphocyte disorders: new etiopathogenetic clues as a rationale for innovative therapeutic approaches.Human leukocyte antigens (HLA)-Cw as prognostic indicators in autologous transplantation for lymphoma.Demonstration of aberrant T-cell and natural killer-cell antigen expression in all cases of granular lymphocytic leukaemia.Lymphoproliferative disease of granular lymphocytes with T-cell receptor gamma delta-positive phenotype: restricted usage of T-cell receptor gamma and delta subunit genes.Increased expression of c-maf in pure red cell aplasia secondary to plasma cell dyscrasia.A sustained response to low dose interferon-alpha in a case of refractory pure red cell aplasia.Characteristic expansion of CD45RA CD27 CD28 CCR7 lymphocytes with stable natural killer (NK) receptor expression in NK- and T-cell type lymphoproliferative disease of granular lymphocytes.Rational management approach to pure red cell aplasia.Anti-erythropoietin receptor antibody-associated pure red cell aplasia accompanied by Coombs-negative autoimmune hemolytic anemia in a patient with T cell/histiocyte-rich large B cell lymphoma.Pure red cell aplasia complicating the course of long-standing mantle cell lymphoma.Clinical use of cyclosporine as an adjunctive therapy in the management of feline idiopathic pure red cell aplasia.Chronic lymphocytic leukemia-associated pure red cell aplasia.Pure red cell aplasia and lymphoproliferative disorders: an infrequent association.
P2860
Q32044990-F3B74E85-AEBA-4749-B3D4-16433AAA3443Q33370045-ABFC82C0-84D0-4A8B-BC49-5D94AFD36D40Q33407866-81B41455-E70A-48CA-A653-AB0D23A36EB3Q34135285-F40289E9-0326-4D06-9B26-E78E2534746AQ35136867-C2B07506-852B-4914-9DC5-580D16ACD189Q35954307-44F369F5-4A06-4B6F-A2B9-705D99AD6622Q36285363-97B0345C-EC29-482C-AEAD-28C3D11A891AQ36687986-6B3EA534-0883-4635-AF5A-08D51E96DBCAQ37069554-AB94097E-DBA5-4491-9552-4DE9B6625B18Q37098105-4CDF3388-AF60-4882-88DC-37C2ECE68C46Q37567637-BFCD7187-D1DC-4EB4-BBB2-CAD86C864E7EQ37910960-2A117D32-6BF3-4D6A-B22F-2CC5E51719A7Q38199176-D8F03A72-A325-419C-8FD9-F723302519ACQ40405247-0AD94422-51B9-47F6-A307-66760C8034A8Q41162138-C339563A-694E-4BC7-976F-84D7753428B2Q41307812-193FDBFE-3D82-49B7-8455-19502944CE3DQ41982725-D1A58C5E-AC4D-4EE6-B03E-F1FD968DE280Q42574009-B9E6D1B3-64D3-4BF5-9206-6BD88C2E7949Q43679248-9F1E2B67-2214-4C21-B0C3-945BA2DE35CAQ44369405-1AA04A29-DE43-4A31-A0AD-28F41BFBC734Q44375755-601BDABC-630B-44C4-9E7F-C1EFFD682EF6Q44398750-89C45497-E704-4F9E-87C2-93D4C078C907Q45043881-6141A26A-9D09-429E-97FC-1E97B63E32EEQ47339203-2D49945A-8A82-4F49-AC07-ADE5CEB57785Q47584782-A39A28EF-0CBF-4719-82ED-E232AF417060Q50463392-B6C53333-0224-4F9D-9047-7871026DDC05Q50475827-C2015C08-8E66-419D-93E0-06A6C4BB129EQ50526614-1A8FD7B3-CBF8-47EB-A745-EFBC06F1AACFQ50606472-5745EAB1-C0B9-4930-ABDF-3E6879DC58C4Q55619230-A8D94E27-05E2-491E-9006-3E9174A4C84E
P2860
Pure Red-Cell Aplasia Associated with Clonal Expansion of Granular Lymphocytes Expressing Killer-Cell Inhibitory Receptors
description
im Januar 1999 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в січні 1999
@uk
name
Pure Red-Cell Aplasia Associat ...... ller-Cell Inhibitory Receptors
@en
Pure Red-Cell Aplasia Associat ...... ller-Cell Inhibitory Receptors
@nl
type
label
Pure Red-Cell Aplasia Associat ...... ller-Cell Inhibitory Receptors
@en
Pure Red-Cell Aplasia Associat ...... ller-Cell Inhibitory Receptors
@nl
prefLabel
Pure Red-Cell Aplasia Associat ...... ller-Cell Inhibitory Receptors
@en
Pure Red-Cell Aplasia Associat ...... ller-Cell Inhibitory Receptors
@nl
P2093
P1476
Pure Red-Cell Aplasia Associat ...... ller-Cell Inhibitory Receptors
@en
P2093
Andreas Geiselhart
Lothar Kanz
Oliver Teuffel
Paul Fisch
Roger Grau
Rupert Handgretinger
Wolfgang Bethge
P304
P356
10.1056/NEJM199901283400405
P407
P50
P577
1999-01-28T00:00:00Z